Skip to main content
SpringerLink
Log in

Pathogenesis and Treatment of Multinodular Goiter

  • Chapter
Thyroid Cancer

Part of the book series: Endocrine Updates ((ENDO,volume 2))

Abstract

It may not be altogether evident, why a chapter on multinodular goiter is included in this book on thyroid cancer, since the transformation of the thyroid gland into a multinodular goiter has been considered during a whole century to result from a non-neoplastic, adaptive process triggered and maintained by iodine deficiency. However, within the past two decades, multinodular goiter and, in particular, goiter nodules have gradually been moved into the list of true thyroid neoplasias. This chapter will therefore focus on the events that entailed this shift of paradigm1.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Studer H, Ramelli F. Simple goiter and its variants: Euthyroid and hyperthyroid multinodular goiter. Endocr Rev 1982; 3:40–62.

    PubMed  CAS  Google Scholar 

  2. Studer H, Peter HJ, Gerber H. Natural heterogeneity of thyroid cells: The basis for understanding thyroid function and nodular goiter growth. Endocr Rev 1989; 10:125–135.

    PubMed  CAS  Google Scholar 

  3. Studer H, Derwahl M. Mechanisms of nonneoplastic endocrine hyperplasia - A changing concept: A review focused on the thyroid gland. Endocr Rev 1995; 16:411–426.

    PubMed  CAS  Google Scholar 

  4. Studer H, Gerber H. Multinodular goiter. In: DeGroot L (ed) Endocrinology, ed. 3 Saunders Philadelphia, 1995; 769–782.

    Google Scholar 

  5. Hedinger C, Williams ED, Sobin LH. Histological typing of thyroid tumors. WHO, international histological classification of tumors, ed. 2, Springer, Berlin, 5–6, 1989.

    Google Scholar 

  6. Namba H, Matsuo K, Fagin JA. Clonal composition of benign and malignant human thyroid tumors. J Clin Invest 1990; 86:120–125.

    PubMed  CAS  Google Scholar 

  7. Fey MF, Peter HJ, Hinds HI, Zimmermann A, Liechti-Gallati S, Gerber H, Studer H, Tobler A. Clonal anlaysis of human tumors with M27ß, a highly informative polymorphic X chromosomal probe. J Clin Invest 1991; 89:1438–1444.

    Google Scholar 

  8. Hicks DG, LiVolsi, VA, Neldich JA, Puck JM, Kant JA. Clonal analysis of solitary follicular nodules in the thyroid. Am J Path 1990; 137:553–562.

    PubMed  CAS  Google Scholar 

  9. Kopp P, Jaggi R, Tobler A, Borisch B, Oestreicher M, Sbacan L, Jameson JL, Fey M. Clonal X- inactivation analysis of human tumors using the human androgen receptor gene (HUMARA) polymorphism: a nonradioactive and semiquantitative strategy applicable to fresh and archival tissue. Mol Cell Probes 1997; 11:217–228.

    PubMed  CAS  Google Scholar 

  10. Kopp P, Aeschimann S, Asmis L, Tobler A, Fey MF, Studer H. Polyclonal and clonal nodules may coexist within multinodular goiters. J Clin Endocrinol Metab 1994; 79:134–139.

    PubMed  CAS  Google Scholar 

  11. Aeschimann S, Kopp PA, Kimura ET, Zbaeren J, Tobler A, Fey MF, Studer H. Morphological and functional polymorphism within clonal thyroid nodules. J Clin Endocrinol Metab 1993; 77:846–851.

    PubMed  CAS  Google Scholar 

  12. Aeschimann S, Buergi U, Wagner HE, Kaempf J, Lauber K, Studer H. Low intrathyroidal iodine concentration in non-endemic human goiters: a consequence rather than a cause of autonomous goiter growth. J Endocrinol 1994; 140:155–164.

    PubMed  CAS  Google Scholar 

  13. Brabant G, Bergmann P, Kirsch CM, Köhrle J, Hesch RD, von zur Mühlen A. Early adaptation of thyrotropin and thyroglobulin secretion to experimentally decreased iodine supply in man. Metabolism 1992; 41: 1093–1096.

    PubMed  CAS  Google Scholar 

  14. Peter HJ, Gerber H, Studer H, Smeds S. Pathogenesis of heterogeneity in human multinodular goiter. A study of growth and function of thyroid tissue transplanted onto nude mice. J Clin Invest 1985; 76:1992–2002.

    PubMed  CAS  Google Scholar 

  15. Peter HJ, Studer H, Forster R, Gerber H. The pathogenesis of hot and cold follicles in multinodular goiters. J Clin Endocrinol Metab 1982; 55: 941–946.

    PubMed  CAS  Google Scholar 

  16. Griffin JE, Allman DR, Durrant JL, Wilson JD. Variation in 5a-reductase activity in cloned human fibroblasts. J Biol Chem 1981; 256:3662–3666.

    PubMed  CAS  Google Scholar 

  17. Davies TF, Yang C, Platzer M. Cloning the Fisher rat thyroid cell line FRTL5. Endocrinology 1987; 121:78–83.

    PubMed  CAS  Google Scholar 

  18. Asmis LM, Kaempf J, von Grünigen C, Kimura ET, Wagner HE, Studer H. Acquired and naturally occurring resistance of thyroid follicular cells to the growth inhibitory action of transforming growth factor (31(TGF pl). J Endocrinol 1996; 149:485–496.

    PubMed  CAS  Google Scholar 

  19. Aeschimann S, Gerber H, von Gruenigen C, Oestreicher M, Studer H. The degree of inhibition of thyroid follicular cell proliferation by iodine is a highly individual characteristic of each cell and profoundly differs in vitro and in vivo. Eur J Endorinol 1994; 130:595–600.

    CAS  Google Scholar 

  20. Peter HJ, Gerber H, Studer H, Groscurth P, Zakarija M. Comparison of FRTL-5 growth in vitro with that of xenotransplanted cells and the thyroid of the recipient mouse. Endocrinology 1991; 128:211–219.

    PubMed  CAS  Google Scholar 

  21. Derwahl M, Studer H, Huber G, Gerber H, Peter HJ. Intercellular propagation of individually programmed growth bursts in FRTL-5 cells. Implications for interpreting growth factor actions. Endocrinology 1990; 127:2104–2110.

    PubMed  CAS  Google Scholar 

  22. Peter HJ, Gerber H, Studer H, Becker DV, Peterson ME. Autonomy of growth and of iodine metabolism in hyperthyroid feline goiters transplanted onto nude mice. J Clin Invest 1987; 80:491–498.

    PubMed  CAS  Google Scholar 

  23. Peter FU, Studer H, Groscurth P. Autonomous growth, but not autonomous function, in embryonic human thyroids. A clue to understanding autonomous goiter growth? J Clin Endocrinol Metab 1988; 66:968–973.

    PubMed  CAS  Google Scholar 

  24. Peter HJ, Gerber H, Studer H, Peterson ME, Becker DV,Groscurth P. Autnonomous growth and function of cultured thyroid follicles from cats with spontaneous hyperthyroidism. Thyroid 1991; 1:331–338.

    PubMed  CAS  Google Scholar 

  25. Gerber H, Peter FU, Bösiger J, Studer H, Drews R, Ferguson DC, Becker DV. Different continuous cell lines from adenomatous feline goiters widely differ in morphological, functional and growth aspects. In: Gordon A, Gross J, Hennemann G (eds.) Progress in Thyroid Research, Balkema, Rotterdam, 1991; 541–544.

    Google Scholar 

  26. Huber G, Derwahl M, Kaempf J, Peter HJ, Gerber H, Studer H. Generation of intercellular heterogeneity of growth and function in cloned rat thyroid cells (FRTL5). Endocrinology 1990; 126:1639–1645.

    PubMed  CAS  Google Scholar 

  27. Absher PM, Absher RG, Barnes WD. Genealogies of clones of diploid fibroblasts. Cinematographic observations of cell division patterns in relation to population age. Exp Cell Res 1974; 88:95–104.

    PubMed  CAS  Google Scholar 

  28. Martin GM, Sprague CA, Norwood TH, Pendergrass WR. Clonal selection, attenuation and differentiation in an in vitro model of hyperplasia. Am J Path 1974; 74:137–154.

    PubMed  CAS  Google Scholar 

  29. Studer H, Gerber H, Zbaeren J, Peter HJ. Histomorphological and immunohistochemical evidence that human nodular goiters grow by episodic replication of multiple clusters of thyroid follicular cells. J Clin Endocrinol Metab 1992; 75:1151–1158.

    PubMed  CAS  Google Scholar 

  30. Smeds S, Peter HJ, Jörtsô E, Gerber H, Studer H. Naturally occurring clusters of rapidly replicating follicular cells in mouse thyroid glands. Cancer Res 1987; 47:1646–1651.

    PubMed  CAS  Google Scholar 

  31. Groch KM, Clifton KH. The effects of goitrogenesis, involution and goitrogenic rechallenge on the clonogenic cell content of the rat thyroid. Acta Endocrinol (Copenh) 1992; 126:515–523.

    CAS  Google Scholar 

  32. Smith P, Wynford-Thomas D. Control of thyroid follicular cell proliferation - cellular aspects. In: Wynford-Thomas D, Williams ED (eds) Thyroid Tumours. Churchill Livingstone, London, 1989; 66–90.

    Google Scholar 

  33. Feder N. Solitary cells and enzyme exchange in tertaparental mice. Nature 1976; 263:67–69.

    PubMed  CAS  Google Scholar 

  34. Logothetopoulos J. Growth and function of the thyroid gland in rats injected with L-thyroxine from birth to maturity. Endocrinology 1963; 73:349–352.

    PubMed  CAS  Google Scholar 

  35. Majack RI. Extinction of autonomous growth potential in embryonic: adult vascular smooth muscle cells heterokaryons. J Clin Invest 1995; 95: 464–468.

    PubMed  CAS  Google Scholar 

  36. Aebi U, Gerber H, Studer H. Thyroid adenomas: a morphologically and functionally heterogeneous thyroid disease. In: Gordon A, Gross J, Hennemann G (eds) Progress in Thyroid Research, Balkema, Rotterdam, 1991; pp. 679–682.

    Google Scholar 

  37. Namba H, Ross JL, Goodman D, Fagin JA. Solitary polyclonal autonomous thyroid nodule: a rare cause of childhood hyperthyroidism. J Clin Endocrinol Metab 1991; 72:1108–1112.

    PubMed  CAS  Google Scholar 

  38. Schürch M, Peter HJ, Gerber HJ, Studer H. Cold follicles in a multinodular human goiter arise partly from a failing iodide pump or and partly from deficient iodine organification. J Clin Endocrinol Metab 1990;71:1224–1229.

    PubMed  Google Scholar 

  39. Spitzweg C, Job AW, Heufelder AE. Analysis of human iodide symporter gene expression in patients with thyroid diseases. 79th Meeting Endocrine Soc, 1997; Abstract 30–1, p. 108.

    Google Scholar 

  40. Rentsch HP, Studer H, Frauchiger B, Siebenhüner L. Topographical heterogeneity of basal and thyrotropin-stimulated adenosine 3’,5’-monophosphate in human nodular goiter. J Clin Endocrinol Metab 1981; 53:514–521.

    PubMed  CAS  Google Scholar 

  41. Hamacher Ch, Studer H, Zbaeren J, Schatz H, Derwahl M. Expression of functional stimulatory guanine nucleotide binding protein in nonfunctioning thyroid adenomas is not correlated to adenylate cyclase activity and growth of these tumors. J Clin Endocrinol Metab 1995; 80:1724–1732.

    PubMed  CAS  Google Scholar 

  42. Conti A, Kneubuehl, F, Studer H, Kohler H, Buergi H. Increased iodotyrosine deiodinase in human goiters and in rats treated with perchlorate. In: Robbins J, Braverman LE (eds) Thyroid Research, Excerpta Medica, Amsterdam 1975; 166–168.

    Google Scholar 

  43. Gullino PM. Natural history of breast cancer. Progression from hyperplasia to neoplasia as predicted by angiogenesis. Cancer 1977; 39:2697–2703.

    PubMed  CAS  Google Scholar 

  44. Studer H, Hunziker HR, Ruchti C. Morphologic and functional substrate of thyrotoxicosis caused by nodular goiters. Am J Med 1978; 65:272–234.

    Google Scholar 

  45. Gemsenjäger E, Staub JJ, Girard J, Heitz PH. Preclinical hyperthyroidism in multinodular goiter. J Clin Endocrinol Metab 1967; 43:810–816.

    Google Scholar 

  46. Laurberg P, Pederssen KM, Vestergard H, Sigurdsson G. High incidence of multinodular toxic goiter in the elderly population in a low iodine intake area vs. high incodence of Graves’ disease in the young in a high iodine intake area. J Int Med 1991; 229:415–420.

    CAS  Google Scholar 

  47. Fenzi GF, Ceccarelli C, Macchia E. Reciprocal changes of serum thyroglobulin and TSH in residents of a moderate endemic goiter area Clin Endocrinol (Oxf) 1985; 23:115–122.

    CAS  Google Scholar 

  48. Rieu M, Bekka S, Sambor B, Berrod JL, Fombeur JL. Prevalence of subclinical hyperthyroidism and relationship between thyroid hormonal status and thyroid ultrasonsographic parameters in patients with non-toxic nodular goiters. Clin Endocrinol (Oxf) 1993; 39:67–71.

    CAS  Google Scholar 

  49. Duprez L, Hermans J, van Sande J, Dumont J, Vassart G, Parma J. Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene. J Clin Endocrinol Metab 1997; 82:306–308.

    PubMed  CAS  Google Scholar 

  50. Harrer P, Broecker M, Zint A, Zumtobel V, Derwahl M. Thyroid nodules in recurrent multinodular goiters are predominantly polyclonal J Endocrinol Invest 1998; (in press)

    Google Scholar 

  51. Ohno T, Stribley JA, Wu G, Hinrichs SH, Weisenburger DD, Chan WC. Clonality in nodular lymphocyte-predominant Hodgkin’s disease. N Engl J Med 1997; 337:459–465.

    PubMed  CAS  Google Scholar 

  52. Gutierrez MI, Bhatia K, Chemey B, Capello D, Gaidano G, Magrath I. Intraclonal molecular heterogeneity suggests a hierarchy of pathogenetic events in Burkitt’s lymphoma. Ann Oncol 1997; 8:987–994.

    PubMed  CAS  Google Scholar 

  53. Schwartzman RA, Cidlowski JA. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr Rev 1993; 14:133–151.

    PubMed  CAS  Google Scholar 

  54. Bröcker M, de Buhr I, Papageorgiou G, Schatz H, Derwahl M. Expression of apoptosis-related proteins in thyroid tumors and thyroid carcinoma cell lines. Exp Clin Endocrinol Diabetes 1996; 104: 20–23.

    PubMed  Google Scholar 

  55. Gerber H, Zbaeren J, Kopp P, Aeschimann S, Maciel R, Studer H. Human nodular goiters grow by episodic replication of disseminated cell cohorts expressing several growth factors at the same time. J Endocr Invest 1992; 15 [Suppl 2]:Abstract 95.

    Google Scholar 

  56. Minuto F, Barreca A, Del Monte P, Cariola G, Torre GC, Giordano G. Immunoreactive insulin-like growth factor I (IGF-1) and IGF-binding protein content in human thyroid tissue. J Clin Endocrinol Metab 1989; 68:621–626.

    PubMed  CAS  Google Scholar 

  57. Vanelli GB, Bami T, Modigliani U, Paulin I, Serio M, Maggi M, Fiorelli G, Balboni GC. Insulin-like growth factor-I receptors in nonfunctioning thyroid nodules. J Clin Endocrinol Metab 1990; 71:1175–1182.

    Google Scholar 

  58. Di Carlo A, Mariano A, Pisano G, Parmeggiani U, Beguinot L, Macchia V. Epidermal growth factor and thyrotropin response in human thyroid tissues. J Endocrinol Invest 1990; 13:293–299.

    PubMed  Google Scholar 

  59. Westermark, K, Lundqvist M, Wallin G, Dahlman T, Hacker GW, Heldin NE, Grimelius L. EGF-receptors in human normal and pathological thyroid tissue. Histopathology 1996; 28:221–227.

    PubMed  CAS  Google Scholar 

  60. Gärtner R, Veitenhansl M, Atkas J, Schophol D. Role of basis fibroblast growth factor in the pathogenesis of nodular goiter. Exp Clin Endocrinol Diabetes 1996; 104:36–38.

    PubMed  Google Scholar 

  61. Morosini PP; Taccaliti A, Montironi R, Scarpelli M, Diamanti L, Simonella G, Mancini V, Petrelli MD, Mantero F. TGF-beta 1 immunohistochemistry in goiter: comparison of patients with recurrence or no recuurence. Thyroid 1996; 6:417–422.

    PubMed  CAS  Google Scholar 

  62. Derwahl M, Hamacher Ch, Russo D et al. Constitutive activation of the Gsa-protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid. J Clin Endocrinol Metab 1996; 81:1898–1904.

    PubMed  CAS  Google Scholar 

  63. Rubin H, Chow M, Yao A. Cellular aging, destabilization, and cancer. Proc. Natl. Acad. Sci. USA 1991; 93:1825–1830.

    Google Scholar 

  64. Chow M, Rubin H. Irreversibility of cellular aging and neoplastic transformation: a clonal analysis. Proc. Natl. Acad. Sci. USA 1996; 93:9793–9798.

    PubMed  CAS  Google Scholar 

  65. Bishop JM. Molecular themes in oncogenesis. Cell 1991; 64:235–248.

    PubMed  CAS  Google Scholar 

  66. Namba H, Gutman RA, Matsuo K, Alvarez A, Fagin JA. H-ras protooncogene mutations in human thyroid neoplasms. J Clin Endocrinol Metab 1990; 71:223–229.

    PubMed  CAS  Google Scholar 

  67. Dumont JE, Lamy F, Roger P, Maenhaut C. Physiological and pathological regulation of thyoid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev 1992; 72:667–679.

    PubMed  CAS  Google Scholar 

  68. Studer H, Gerber H. Toxic multinodular goiter. In: Braverman LE, Utiger RE (eds.) The Thyroid, ed. 6 Lippincott, Philadelphia, 1991; pp 692–697, 1107–1117.

    Google Scholar 

  69. Westenmark K, Karlsson FA, Westenmark B. Thyrotropin modulates EGF receptor function in porcine thyroid follicle cells. Mol Cell Endocrinol 1985; 40:17–23.

    Google Scholar 

  70. Hofbauer LC, Rafferzeder M, Janssen 0E, Gärtner R. Insulin-like growth factor I messenger ribonucleic acid expression in porcine thyroid follicles is regulated by thyrotropin and iodine. Eur J Endocrinol, 1995; 132(5):605–610.

    PubMed  CAS  Google Scholar 

  71. Burikhanov R, Coulonval K, Pinson I, Lamy F, Dumont JE, Roger PP. Thyrotropin via cyclic AMP induces insulin receptor expression and insulin co-stimulation of growth and amplifies insulin and insulin-like growth factor signaling pathways in dog thyroid epithelial cells. J Biol Chem, 1996; 271 (46):29400–29406.

    PubMed  CAS  Google Scholar 

  72. Eggo MC, King WJ, Black EG, Sheppard MC. Functional human thyroid cells and their insulin-like growth factor-binding proteins: regulation by thyrotropin cyclic 3’,5’ adenosine monophosphate, and growth factors. J Clin Endocrinol Metab 1996; 81:3056–3062.

    PubMed  CAS  Google Scholar 

  73. Cheung NW, Boyages SC. The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol (Oxf), 1997; 46:545–549.

    CAS  Google Scholar 

  74. Williams DW, Williams ED, Wynford-Thomas D. Evidence for autocrine production of IGF-1 in human thyroid adenomas. Mol Cell Endocrinol 1989; 61:139–143.

    PubMed  CAS  Google Scholar 

  75. Derwahl M. Editorial: TSH receptor and Gs-alpha gene mutations in the pathogenesis of toxic thyroid adenomas: a note of caution. J Clin Endocrinol Metab 1996; 81:1–3.

    Google Scholar 

  76. Russo D, Arturi F, Schlumberger M, Caillou B, Monier R, Filetti S, Suarez HG. Activating muations of the TSH receptor in differentiated thyroid carcinomas. Oncogene 1995; 11:1907–1911.

    PubMed  CAS  Google Scholar 

  77. Holzapfel HP, Fuhrer D, Wonerow P, Weinland G, Scherbaum WA, Paschke R. Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters. J Clin Endocrinol Metab 1997; 82: 4229–4233.

    PubMed  CAS  Google Scholar 

  78. Suarez HG, du Villard JA, Caillou B, Schlumberger M, Parmentier C, Monier R. gsp mutations in human thyroid tumours. Oncogene 1991; 6:677–679.

    PubMed  CAS  Google Scholar 

  79. Parma J, van Sande J, Swillens S, Tonacchera M, Dumont J, Vassart G. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas; identification of additional mutations activating both the cyclic adenosine 3’S’monophosphate and inositol phosphate-Ca2+ cascades. Mol Endocrionol 1995; 9:725–733.

    CAS  Google Scholar 

  80. Ivan M, Ludgate M, Gire V, Bond JA, Wynford-Thomas D. An amphotropic retroviral vector expressing a mutant gsp oncogene: effects on human thyroid cells in vitro. J Clin Endocrinol Metab 1997; 82:2702–2708.

    PubMed  CAS  Google Scholar 

  81. Muca C, Vallar L. Expression of mutationally activated G alpha stimulates growth and differentiation of thyroid FRTL5 cells. Oncogene, 1994; 9:3647–3653.

    PubMed  CAS  Google Scholar 

  82. Porcellini A, Ruggiano G, Pannain S, Ciullo I, Amabile G, Fenzi G, Avvedimento EV. Mutations of thyrotropin receptor isolated from thyroid autonomous functioning adenomas confer TSH-independent growth to thyroid cells. Oncogene 1997; 15:781–179.

    PubMed  CAS  Google Scholar 

  83. Michiels FM, Caillou B, Talbot M, Dessaps-Freichey F, Maunoury MT, Schlumberger M, Mercken L, Monier R, Feunteun J. Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice. Proc Natl Acad Sci USA 1994; 91:10488–10492.

    PubMed  CAS  Google Scholar 

  84. Zeiger MA, Saji M, Gusev, Y, Westra WH, Takiyama Y, Dooley WC, Kohn LD, Levine MA. Thyroid-specific expression of cholera toxin Al subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice. Endocrinology 1997; 138:3133–3140.

    PubMed  CAS  Google Scholar 

  85. Studer H, Huber G, Derwahl M, Frey P. Die Umwandlung von Basedowstrumen in Knotenkröpfe: ein Grund des Hyperthyreoserezidivs. Schweiz med Wschr 1989; 119:203–208.

    PubMed  CAS  Google Scholar 

  86. Kopp P, van Sande J, Parma J et al. Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med 1995; 332:150–154.

    PubMed  CAS  Google Scholar 

  87. Duprez L, Parma J, Van Sande J et al. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nature Genet 1994; 7:396–401.

    PubMed  CAS  Google Scholar 

  88. Abs R, Stevenaert A, Beckers A. Autonomously functioning thyroid nodules in a patient with thyrotropin-secreting pituitary adenoma: possible cause-effect relationship. Eur J Endocrinol 1994; 131:355–358.

    PubMed  CAS  Google Scholar 

  89. Vesely DI. Selective pituitary resistance to thyroid hormones after treatment of a toxic multinodular goiter. South Med J 1988; 81:1173–1176.

    PubMed  CAS  Google Scholar 

  90. Williams DW, Williams ED, Wynford-Thomas D. Loss of independence on IGF-I for proliferation of human thyroid adenoma cells. Br J Cancer 1988; 57:535–359.

    PubMed  CAS  Google Scholar 

  91. Hintze G, Emrich D, Köbberling J. Treatment of endemic goitre due to iodine deficiency with iodine, levothyroxine or both: results of a multicentre trial. Europ J Clin Invest 1989; 19:527–534.

    PubMed  CAS  Google Scholar 

  92. Gärtner R, Dugrillon A, Bechtner G. Evidence that iodolactones are the mediators of growth inhibition by iodine on the thyroid. Acta Med Austriaca, 1996; 23:47–51.

    PubMed  Google Scholar 

  93. Hay ID, Reading CC, Carbonau JW. High-resolution realtime ultrasonography and unsuspected micronodular thyroid disease [letter]. Lancet 1984; 1:916.

    PubMed  CAS  Google Scholar 

  94. Mortensen JD, Woolner LB, Bennet WA. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 1955; 15:1270–1276.

    PubMed  CAS  Google Scholar 

  95. Morita T, Tamai H, Ohshima A, Komaki G, Matsubayashi S, Kuma K, Nakagawa T. Changes in serum thyroid hormone, thyrotropin and thyroglobulin concentration during thyroxine therapy in patients with solitary thyroid nodules. J Clin Endocrinol Metab 1989; 69:227–230.

    PubMed  CAS  Google Scholar 

  96. Celani MF, Mariani M, Mariani G. On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign solitary, solid or predominantly solid, thyroid nodules. Acta Endocrinol (Copenh) 1990; 123:603–608.

    CAS  Google Scholar 

  97. Gharib H, James EM, Charboneau JW, Naesens JM, Offord KP, Gorman CA. Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med 1987; 317:70–75.

    PubMed  CAS  Google Scholar 

  98. Papini, Bacci V, Panunzi C, Pacella CM, Fabbrini R, Bizzarri G, Petrucci L, Giammarco V, La Medica P, Masala M et al. A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules. Clin Endocrinol (0xf) 1993; 38:507–513.

    CAS  Google Scholar 

  99. Cheung PS, Lee JM, Boey JH. Thyroxine suppressive therapy of benign solitary thyroid nodules: a prospective randomized study. World J Surg 1989; 13:818–822.

    PubMed  CAS  Google Scholar 

  100. Celani MF. Levothyroxine suppressive therapy in the medical management of nontoxic benign multinodular goiter. Exp Clin Endocrinol 1993; 101:326–332.

    PubMed  CAS  Google Scholar 

  101. La Rosa GL, Lupo L, Giuffrida D, Gullo d, Vigneri R, Belfiore A. Levothyroxine and potassium iodide are both effective in treating benign solid cold nodules of the thyroid. Ann Intern Med 1995; 122:1–8.

    PubMed  Google Scholar 

  102. Lima N, Knobel M, Cavaliere H, Sztejnsznajd C, Tomimori E, Medeiros-Neto G. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Thyroid 1997; 7:691–697.

    PubMed  CAS  Google Scholar 

  103. La Rosa GL, Ippolito AM, Lupo L, Cercabene G, Santonocito MG, Vigneri R, Belfiore A. Cold thyroid nodule reduction with L-thyroxine can be predicted by initial nodule volume and cytological characteristics. Clin Endocrinol Metab 1996; 81:4385–4387.

    Google Scholar 

  104. Badillo J, Shimaoka K, Lessmann EM, Marchetta FC, Sokal JE. Treatment of nontoxic goiter with sodium liothyronine. JAMA 1963; 184:151–158.

    Google Scholar 

  105. Berghout A, Wiersinga WM, Drexhage HA, Smits NJ, Touber JL. Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre. Lancet 1990; 336:193–197.

    PubMed  CAS  Google Scholar 

  106. Nygaard B, Hegedus L, Gervil M, Hjalgrim H, Soe-Jensen P, Hansen JM. Radioiodine treatment of multinodular non-toxic goitre. BMJ 1993; 307:828–832.

    PubMed  CAS  Google Scholar 

  107. Huysmans DA, Buijs WC, van den Ven MT, van den Broek WJ, Kloppenburg PW, Hermus AR, Corstens FH. Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters. J Nuc Med 1996; 37:2072–2079.

    CAS  Google Scholar 

  108. Huysmans D, Hermus A, Edelbroek M, Barentsz J, Corstens F, Kloppenburg P. Radioiodine for nontoxic multinodular goiter. Thyroid 1997; 7:235–239.

    PubMed  CAS  Google Scholar 

  109. Huysmans AK, Hermus RM, Edelbroek MA, Tjabbes T, Oostdijk, Ross HA, Corstens FH, Kloppenburg PW. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters. Thyroid 1997; 7:535–539.

    PubMed  CAS  Google Scholar 

  110. Livraghi T, Paracchi A, Ferrari C, Bergonzi M, Grarvaglia G, Ranieri P, Vetorri C. Treatment of autonomous thyroid nodules with percutaneous ethanol injection: preliminary results. Work in progress. Radiology 1990; 175:827–829.

    PubMed  CAS  Google Scholar 

  111. Verde G, Papini E, Pacell CM, Gallotti S, Strada S, Fabbrini R, Bizzarri G, Rinaldi R, Panunzi C et al. Ultrasound guided percutaneous ethanol injection in the treatment of cystic thyroid nodules. Clin Endocrinol (Oxf) 1994; 41:719–724.

    CAS  Google Scholar 

  112. Papini E, Pacella CM, Verde G. Percutaneous ethanol injection (PEI): what is the role in the treatment of benign thyroid nodules? Thyroid 1995; 5:147–150.

    PubMed  CAS  Google Scholar 

  113. Lippi F, Ferrari C, Manetti L, Rago T, Santini F, Monzani F, Bellitti P, Papini E, Busnardo B, Angelini F, Pinchera A. Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter study. The Multicenter study group. J Clin Endocrinol Metab 1996; 81:3261–3264.

    PubMed  CAS  Google Scholar 

  114. Ferrari C, Reschini E, Paacchi A. Treatment of the autonomous thyroid nodule: a review. Eur J Endocrinol 1996; 135:383–390.

    PubMed  CAS  Google Scholar 

  115. Monzani F, Caraccio N, Goletti O, Lippolis PV, Casolaro A, Del Guerra P, Cavina E, Miccoli P. Five-year follow-up of percutaneous ethanol injection for the treatment of hyperfunctioning thyroid nodules: a study of 117 patients. Clin Endocrinol (Oxf) 1997; 46:9–15.

    CAS  Google Scholar 

  116. Caraccio N, Goletti O, Lippolis PV, Casolaro A, Cavina E, Miccoli P, Monzani F. Is percutaneous ethanol injection a useful alternative for the treatment of the cold benign thyroid nodule? Five years’ experience. Thyroid 1997; 7:699–704.

    PubMed  CAS  Google Scholar 

  117. Bennedbaek FN, Karstrup S, Hegedus L. Percutaneous ethanol injection therapy in the treatment of thyroid and parathyroid diseases. Eur J Endocrinol 1997; 136:240–250.

    PubMed  CAS  Google Scholar 

  118. Singer PA, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG, Braverman LE, Clark OH, McDougall IR, Ain KV, Dorfman SG. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 1996; 156:2165–2172.

    PubMed  CAS  Google Scholar 

  119. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993; 328:553–559.

    PubMed  CAS  Google Scholar 

  120. Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, Regalbuto C, Vigneri R. Cancer risk in patients with cold thyroid nodules: relevance of iodide intake, sex, age and multinodularity. Am J Med 1992; 93:363–369.

    PubMed  CAS  Google Scholar 

  121. Kuma K, Matsuzuka F, Kobayashi A, Hirai K, Morita S, Miyauchi A, Katayama S, Sugawara M. Outcome of long standing solitary thyroid nodules. World J Surg 1992; 16:583–587.

    PubMed  CAS  Google Scholar 

  122. Hung W, Anderson KD, Chandra RS, Kapur SP, Patterson K, Randolph JG, August GP. Solitary thyroid nodules in 71 children and adolescents. J Pediatr Surg 1992; 27:1407–1409.

    PubMed  CAS  Google Scholar 

  123. Pelizzo MR, Bernante P, Toniato A, Fassina A. Frequency of thyroid carcinoma in a recent series of 539 consecutive thyroidectomies for multinodular goiter. Tumori 1997; 83:653–655.

    PubMed  CAS  Google Scholar 

  124. al-Suliman NN, Ryttov NF, Qvist N, Blichert-Toft M, Graversen HP. Experience in a specialist thyroid surgery unit: a demographic study, surgical complications, and outcome. Eur J Surg 1997; 163:13–20.

    PubMed  CAS  Google Scholar 

  125. Bistrup C, Nielsen JD, Gregersen G, Franch P. Preventive effect of levothyroxine in patients operated for non-toxic goitre: a randomized trial of one hundred patients with nine years follow-up. Clin. Endocrinol.Oxf. 1994; 40:323–327.

    PubMed  CAS  Google Scholar 

  126. Rzepka AH, Cissewski K, Olbricht T, Reinwein D. Effectiveness of prophylactic therapy on goiter recurrence in an area with low iodine intake - a sonographic follow-up study. Clin. Investig. 1994; 72:967–970.

    PubMed  CAS  Google Scholar 

  127. Rojdmark J, Jarhult J. High long term recurrence rate after subtotal thyroidectomy for nodular goitre. Eur. J. Surg. 1995; 161:725–727.

    PubMed  CAS  Google Scholar 

  128. Zelmanovitz T, Zelmanovitz F, Genro S, Gus P, de Azevedo MJ, Gross JL. Analysis of the factors associated with recurrence of post-thyroidectomy goiter. Rev. Assoc. Med. Bras. 1995; 41:86–90.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Clinics of Bochum, Germany

    Michael Derwahl

  2. Bern, Switzerland

    Hugo Studer

Authors
  1. Michael Derwahl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hugo Studer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Endocrinology & Metabolism Department of Medicine College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA

    James A. Fagin

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Derwahl, M., Studer, H. (1998). Pathogenesis and Treatment of Multinodular Goiter. In: Fagin, J.A. (eds) Thyroid Cancer. Endocrine Updates, vol 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4945-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4945-1_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7244-8

  • Online ISBN: 978-1-4615-4945-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation